Another cannabis stock is gearing up to trade publicly on the Canadian Stock Exchange (CSE). Tree of Knowledge Inc. (TOK) is the latest company to apply for a listing application on the market, following a growing list that includes headline-making companies such as MedMen (CNSX:MMEN) and The Green Organic Dutchman (TSX:TGOD.
A group of business and medical professionals founded TOK in 2015 with the goal of building a trusted CBD product line. The company also has an advisory board with leaders from diverse sectors from medicine to professional sports. Since then, the company has expanded to three continents and has grown its brand of CBD products called EVRCBD—oils, capsules, tinctures and vape pens.
Courtland Capital and TOK announced their merger agreement in April. Courtland is in the process of forming a Nevada subsidiary company to merge with TOK, whereby TOK shareholders will receive Courtland common shares, owning approximately 88 percent of the outstanding undiluted Courtland shares. The company plans to delist from the TSX Venture Exchange and instead pursue the listing on the CSE. Courtland will change its name to TOK in the reverse merger.
TOK Chairman Michael Caridi explained that TOK and Courtland make a great partnership moving forward in their quest to becoming a medical cannabis industry leader. Caridi cites the sheer magnitude of the medical cannabis market, and looks forward to the “ability to mature and expand [their] reach into the markets [they] are in and plan on entering.”
Doctors have been warned against rushing to prescribe medical cannabis despite Australians’ acceptance of its use.
To date, the evidence on the effectiveness of medical cannabis remains “limited”, said Jennifer Martin and Associate Professor Yvonne Bonomo in an editorial for the Royal Australasian College of Physicians (RACP).
Published in the Medical Journal of Australia, the editorial says the usual regulatory processes designed to protect patients from potential serious harms caused by medicinal cannabinoids must be adhered to.
In Australia, medicinal cannabis is legal but patient access is still very difficult.
The Therapeutic Goods Administration (TGA) Special Access Scheme (SAS) provides patient access to cannabis on compassionate grounds without the usual quality and safety data requirements.
This means approval is granted on a case-by-case basis provided the correct documentation is given by the prescribing doctor, says Dr. John Lawson, a pediatric neurologist and conjoint senior lecturer at the University of New South Wales.
A recent trial published in The New England Journal of Medicine, led by Australian neurologist Professor Ingrid Scheffer, found cannabidiol – one of at least 113 compounds found in the cannabis plant – significantly reduced the severity and frequency of seizures in children with a rare, yet devastating form of epilepsy known as a Dravet syndrome.
Last year, the Medical Cannabis Council called for more robust research to be done to ensure patients greater access in the future.
Read the full article in The Guardian
Spoiler alert for those attending the Winter Fancy Food Show today through Tuesday in San Francisco: There are no cannabis edibles on the trade-show floor. Cannabis cuisine is not the subject of any plenary panel.
In November, the Fancy Food Show’s parent, the Specialty Food Association (SPA), ranked cannabis number eight of the top-10 food trends to watch in 2018.
“As more states legalize recreational marijuana, the varieties of pot-enhanced food and beverage will increase,” the SPA’s Trendspotter Panel wrote last November. “Look out for continued interest and acceptance in a host of snacks, treats and beverages with a little something extra.”
Nielsen is vice president of trends and marketing at CCD Innovation, an Emeryville food, and beverage development agency. She’s attending the Fancy Food Show today through Tuesday at Moscone Center. As a member of the Specialty Food Association’s Trendspotters — an expert panel comprised of marketers, journalists, and other tastemakers — she’ll roam the Fancy Food Show trade-show floor looking for new and innovative products. There are no cannabis edibles at this year’s Fancy Food Show, but the SPA’s Trendspotters won’t have to go far to find them.
There are five retail cannabis stores reachable via short walk, taxi or rideshare. And many of the edibles on sale in these stores look like they might have sneaked over from the show.
Read more at GreenState
Several new rules and regulations for legal cannabis in Colorado have been finalized and will go into effect January 1, 2018, according to the Marijuana Enforcement Division. The MED had been holding stakeholder meetings and accepting public feedback on many of the proposed rules since September; they include updates to packaging regulations, a new state program for medical cannabis research and more.
Many of the new rules are a result of 2017’s legislative session, with amendments to existing laws and new bills forcing updates that affect both the industry workforce and consumers. HB 1034, HB 1261, SB 187 and SB 192 will change employee training methods, business location transfers, product contaminate testing, concentrate wholesalers and packaging and labeling.
Most of the rules were made to increase youth, consumer, and employee safety, the MED says, such as new packaging and labeling requirements that are designed to decrease interaction with minors.
The MED will continue to issue industry bulletins and tips for stakeholders on how to comply with the new rules as they go into effect.
Read the full article at West Word
Hyderabad: Cannabis oil was used by a 69-year-old woman to treat a breast tumour which was diagnosed by doctors in the West.
There have been testimonies which claimed cannabis oil helped cure cancer. According to researchers, cannabis compounds are found to kill malignant cells. However, trials have not yet been carried out on humans.
Dr. Srinivas C., a senior oncologist, said, “These methods have to be researched to be used at the clinical level. Currently, the protocols are chemotherapy, radiotherapy, surgeries and personalized treatment. There are claims made from time to time.”
Cannabis oil is sold legally in the west as a food supplement. Its medical use has not started. A senior oncologist, on condition of anonymity, said, “The integrated therapy, using the Ayurveda and the modern medicine, has started in certain hospitals in the state. It has been found that every human body requires a different set of medications, dosages, and protocols to treat cancer.”
More of this story at Deccan Chronicle
A team of scientists from the American University of Beirut fed Nile tilapia fish pellets laced with cannabis oil to test whether the drug could make the fish reduce stress and grow faster.
These researchers noted that tilapia is farmed intensively, and in a bid to maximize the amount of product fish farmers can bring to market, some fish pens have become incredibly congested. Living in such close quarters can lead to all kinds of challenges for the fish, including reduced water quality, more incidences of disease, and increasing intraspecific interactions, which leads to stress.
As part of the trial, three diets were made to contain either soy oil, industrial hemp oil or cannabis oil and offered to tilapia for 8 weeks. At termination, survival, growth, feed conversion and blood parameters were assessed.
On the other hand, cannabis had no effect on blood cell counts, total plasma protein, hematocrit or lysozyme activity.
The results thus obtained suggest that cannabis does not improve the immune response of tilapia or body composition but does reduce growth rate by increasing metabolic rate.
Therefore, the Lebanese scientists found that the pot pellets did not quite have the mood-altering effect they had hoped for.
Continue Reading at Fish Info & Services Co.Ltd
Yvonne Delarosa Green was awarded the first cannabis business license for Los Angeles County for her dispensary 99 High Tide Collective in Malibu. The city and county of Los Angeles are expected to become the capital of cannabis once the state of California’s regulated adult-use market is up and running.
There is a great deal of confusion over the cannabis licenses in the city versus the county. Los Angeles, the city, hasn’t issued any licenses, and it is rumored that existing dispensaries will have to close until they receive the new 2018 license under the new regulations.
Keith Knox, chief deputy treasurer and tax collector for the county, confirmed that Los Angeles County administers some functions like business permits for three cities and Malibu is one of those three. However, Los Angeles County is banning marijuana for now, which makes the licensing in Malibu even more unique.
The mayor’s office in Malibu said in a statement:
“The City of Malibu’s Municipal Code allows for two medical marijuana dispensaries to operate within City limits. Two medical marijuana dispensaries have been in operation in the City for several years. Los Angeles County issues business licenses on behalf of the City of Malibu, and approved a business license for one of the two existing medical marijuana dispensaries today.”
Read the full article at Forbes
American Chemical Society’s ACS Omega has published a study which claims to be groundbreaking in terms of how we view a very specific type of cannabis consumption, the so-called cannabis oil dabbing.
The study which was published this month finds that dabbing cannabis oil through glass rigs may expose users to elevated toxin levels as compared to other methods, such as smoking dried cannabis or even vaping it for that matter.
In an effort to explain how the chemicals in concentrated cannabis break down under heat, a team of scientists from Portland State University has discovered that concentrates exposed to the high heat common to dab setups produced elevated levels of carcinogenic and toxic compounds.
Dabbing at low temperatures might be the way out
Researchers from PSU said that the key factor in which chemicals get released is the degree of heat used to activate cannabinoids in the oil.
Researchers also found that the higher the temperature that a substance’s flavoring terpenes are subjected to, the more carcinogens, toxins, and potential irritants are produced — meaning that you should dab on as low as possible temperatures.
Read the full article at Greencamp
Detroit voters will have an opportunity to weigh in on the region’s cannabis industry in November when newly proposed regulations appear on the local ballot.
• Amend the definition of a Drug-Free School Zone to correspond to federal and state law that requires dispensaries to be at least 1,000 feet from schools, colleges, and public libraries.
• Amend the definition of a Drug-Free School Zone to correspond to federal and state law that requires dispensaries to be at least 1,000 feet from schools, colleges, and public libraries
• Would allow dispensaries to open within 500 feet of another dispensary. They would also be allowed to open within 500 feet of exempt religious institutions where religious services are conducted regularly. The current ordinance requires facilities to be more than 1,000 feet from churches and other dispensaries.
• Would allow dispensaries to open near liquor, beer/wine stores, child care centers, arcades, and parks. The current ordinance does not allow them to be open near any of them.
• Would allow dispensaries to stay open until 9 p.m. currently, they’re required to close by 8 p.m.
More of this news at Leafly
Cannabis oils are contained, transported, and dispensed from a variety of vessels. “Pucks” and different types of parchments are the most common containers used to package cannabis oils, but the syringe remains the only oil container that can dispense measured doses of cannabis concentrate by design.
The syringe, however, holds an especially loaded place in drug culture for its apparent relationship to intravenous drug use, which is amplified against the backdrop of the opioid epidemic in the United States. The optics of the syringe are challenging to overcome because society shares the preconceived notation that syringes belong in the responsible hands of science and medicine professionals, yet are being abused by hard drug users.
Benefits of Cannabis Oil Syringes
It’s time to push your concerns aside and give this implement a chance. There are myriad benefits of cannabis oil syringes. First, syringes usually come in a variety of volumes. Many have their volume indicated in marks on the body of the syringe, giving you relative measurements for dosage.
Another benefit of the syringe is its minimal to non-existent loss of oil. The plunger in my oil syringe pressed the oil through without losing much to the container. With a puck or parchment, over time oil can get thin and difficult to fully collect. There are different techniques to gather this residual oil, but the syringe requires neither the time nor effort to do so. The full volume is available, measurable, and usable without the fuss of a heating element and tools.
Read the full article at Leafly
As you are likely aware, cannabis is federally illegal under the Controlled Substances Act. This means that transporting any form of cannabis across state lines is considered a felony trafficking offense. Sending cannabis through the mail is no exception and can result in a prison sentence of up to five years for the first offense.
However, more and more often, there have been advertisements offering to ship CBD oil to your home, whether you live in Colorado or Kentucky, across state and federal lines.
The Cannabis sativa L. plant has several different varieties. The non-psychoactive variety is what we commonly refer to as industrial hemp, and contains little to no THC content and small amounts of CBD.
Industrial hemp is legal to import and ship across state lines and process into various products, including the fabled CBD oils, so long as they contain less than 0.3% delta-9 tetrahydrocannabinol.
Continue Reading at Leafly
Botanix yesterday reported to the Australian Securities Exchange its first safety study on humans, the West Australian reported.
The second phase of clinical trials of the treatment will start within months according to Botanix executive director Matthew Callahan.
“Collectively, our findings suggest that, due to the combined lipostatic, antiproliferative and anti-inflammatory effects, CBD has potential as a promising therapeutic agent for the treatment of acne vulgaris,” the study found.
The most common adverse effect was skin dryness according to the first trials.
As the demand for CBD-based products explodes in the U.S. and continues to thrive across the globe, Cannabis-based companies race to develop and introduce the newest and higher quality products to capitalize on themomentum. Much like most of the cannabis and legal medical marijuana market, vendors and manufacturers focus on delivering a high degree of quality infused in their CBD-based products.
Earth Science Tech, Inc. (OTC: ETST), an innovative biotech company focused on cannabis CBD-based (industrial hemp), cannabinoid research and development, nutraceuticals, pharmaceuticals, medical devices is pleased to announce its new wholly-owned subsidiary KannaBidioid Inc. to manufacture and distribute vapes/e-liquids and gummy edibles to target vape/smoke shops.
Kanna (Sceletium tortuosum) is known to elevate mood, decrease anxiety, stress, and tension, and suppress the appetite. In moderate doses, it induces euphoria and acts as a powerful stimulant, but can actually have a sedative effect in larger doses.
Read the full article at Cision
Marijuana is a combination of shredded leaves, stems and flower buds of the Cannabis sativa plant. Marijuana can be smoked, eaten, vaporized, brewed and even taken topically, but most people smoke it.
According to research from the Potency Monitoring Project, the average THC content of marijuana has soared from less than 1 percent in 1972, to 3 to 4 percent in the 1990s, to nearly 13 percent in 2010. Today, some retail marijuana has 30 percent THC or more. The increased potency makes it difficult to determine the short- and long-term effects of marijuana.
How Cannabis is consumed
In a 2010 National Survey on Drug Use and Health (NSDUH), 17.4 million people in the United States said they had used marijuana in the past month.
A 2016 Gallup poll found that one in eight people smoke marijuana and 43 percent of U.S. adults admit to trying it.
Read the full article at Live Science
Police officers in North Carolina got a little more than they bargained for this week, when they tracked down what they thought was a rural cannabis cultivation site, but instead uncovered a half-acre field full of poppy plants ready to be turned into opium, the base form of heroin.
According to CNN, Catawba County Sheriffs went to the rural home of 37 year-old Cody Xiong, who they suspected of growing marijuana. When they got there the man didn’t even attempt to hide his uniquely illicit garden.
The half-acre plot had 2,000 pounds of poppies, with an eventual estimated street value of $500 million.
Xiong will most likely face charges of manufacturing a Schedule II narcotic and drug trafficking, but he will go down in history – Captain Jason Reid of the Catawba County Sheriff’s Office told reporters that the bust was only the second large-scale opium production shut down on U.S. soil.
Patients and activists have long fought for the legalisation of medical cannabis, but, despite mounting evidence pointing to its benefits in both pain relief and the treatment of specific conditions, have always stumbled on strong resistance by mainstream attitudes. According to Health Minister Giorgos Pamboridis, the main problem has been a “widespread, albeit false, notion that it somehow helps legitimise the use of recreational cannabis”.
A set of government-proposed regulations to allow the import, distribution and use of pharmaceutical-grade cannabis, unveiled and put to public consultation in February, would, if approved by parliament, allow government to issue two licences for a period “up to 15 years”.
But the government’s proposal for the drastic overhaul of the law on medical cannabis comes with regulation so detailed and tight, making abuse – by the licensees or recreational users – next to impossible, that, perhaps unsurprisingly, the mood of people like Evdokas is hardly celebratory.
According to this document, each individual has the right “to freely choose from among different treatment procedures” and “to refuse a treatment or a medical intervention”.
A second limitation, Evdokas said, the bill places restrictions on which doctors can prescribe the drug.
Continue reading at Cyprus Mail Online
Cannabinoid is a term that is thrown around a lot in the cannabis industry — but did you know there are many different types of cannabinoids that are found throughout Mother Nature’s complex web?
Phytocannabinoids are the cannabinoids produced by plants.
Endocannabinoids are the cannabinoids produced within the body of humans and animals.
Synthetic Cannabinoids are the cannabinoids produced in a laboratory.
There are also a few common plants we will cover today that contain compounds that mimic the biological activity of the classic cannabinoid but have a slightly different structure. These are called cannabimimetic compounds.
Read more at Marijuana.com
House File 524 was approved by the House today at 3 am (83 to 11), and was passed by the Senate exactly four hours later (33 to 7), sending it to Governor Terry Branstad for final consideration. The proposal would legalize the production and distribution of cannabis oil for those with a qualifying condition who receive a recommendation from a physician. Licensed dispensaries would be established to safely distribute the medicine to patients.
“There are sick Iowans out there that need relief, bottom line,” said the bill’s floor manager, Representative Jarad Klein, R-Keota.
If approved into law, House File 524 would allow the Department of Public Health to approve up to two manufacturers and up to five distributors if cannabis oil. The cannabis oil will be limited to containing no more than 3% tetrahydrocannabinol (THC).
The bill also would expand the list of qualifying conditions to use cannabis oil to include cancer, Parkinson’s disease, multiple sclerosis, HIV/AIDS and others. A medical Cannabidiol Advisory Board would be established within the Department of Public Health to recommend adding or removing qualifying conditions.
The Joint Blog
April 20th is here again, a date well-known by recreational enthusiasts and celebrated as a cannabis culture holiday nationwide, and what was once known only as an inside joke to a few is now much more widely known and accepted in the United States. With 8 states having now legalized recreational marijuana, and dozens more allowing medical marijuana, much of the stigma of openly promoting “420-friendly” characteristics has disappeared, with hundreds of companies now offering special discounts on April 20th.
“The stereotype of a cannabis user has changed a lot with its growing acceptance as a medication, and not just a recreational plant used by some to get ‘high,'” says Rick Hawkins, a scientist with Nutra Pure, the makers of the popular CBD Pure line of CBD oils, “States have issued new regulations allowing medications and supplements derived from the cannabis plant to be available to those who need it most, and the results have been nothing short of impressive.”
Mr. Hawkins was referencing the growing popularity of CBD, the non-psychoactive component of the cannabis plant believed to be the primary cannabinoid responsible for mood support and neuroprotectant effects experienced by recreational users. While CBD does not have any intoxicating effects, access to it has been limited because of its relationship to its chemical cousin, THC. CBD users seeking the health benefits of cannabis without the intoxicating effects often go to great lengths to obtain high concentration cannabidiol products, typically ordering them from states like Washington, Colorado, or Oregon where they are more commonplace.
“We get orders from every state for our CBD oils, but the states that have legalized recreational usage also order the most CBD oil too, ironically,” continued Mr, Hawkins. He believes that is because, as more recreational users of cannabis see positive health effects, the word spreads to health-conscious people in the area who would never smoke cannabis, but have joint pain, insomnia, or mood issues that could be helped with cannabis oil. “Some of the healthiest people I know, that would never touch an illegal drug, swear by cannabis oils and take them every day for their health.”
You also might want to consider packing your bags and moving to Uruguay. The South American country announced yesterday that beginning this July, cannabis will be available over the counter at local pharmacies.
Uruguay legalized marijuana in 2013, becoming the first country in the world to do so, but this year’s regulations will mark the first time residents will be able to walk into a store and purchase their bud.
According to the BBC, presidential aid, Juan Andres Roballo held a press conference to announce the over the counter program.
As a part of the country’s new cannabis program, everyone who purchases marijuana from stores must be on a national registry open only to only long-term residents and Uruguayan citizens. So while buying bud won’t be as easy as purchasing a pack of cigarettes, the pharmacy cannabis will be sold for a fixed price of $1.30 per gram – a pretty good bargain if you ask us.
The regulations and registry mean that Uruguay probably isn’t poised to be the next cannabis tourism hot spot, but it will make life easier for residents hoping to get their weed without hassle.
Uruguay’s government has initially signed up 16 pharmacies to launch the program but plans to add more as the registry builds.